Results 201 to 210 of about 10,317 (226)

[Ocular myasthenia gravis].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2013
Ocular myasthenia gravis, although clinically often characterized by typical classical features, can cause considerable diagnostic problems. This article aims to provide a pragmatic approach to the pathogenesis, clinical features, diagnostics and therapeutic strategies in the clinical routine.
S, Pitz, B, Jordan, S, Zierz
openaire   +1 more source

Myasthenia Gravis: Systemic and Ocular Considerations

Ophthalmology, 1979
In the early 1930s, the neuromuscular junction was identified as the site of the abnormality in myasthenia gravis, based on the response of patients to anticholinesterase medication.3 It has since become apparent that acetylcholine, the natural transmitter, is synthesized chiefly in the motor nerve terminals4 and is stored in vesicles for subsequent ...
openaire   +2 more sources

Peribulbar Corticosteroids for Ocular Myasthenia Gravis

Journal of Neuro-Ophthalmology
Background: Ocular myasthenia gravis is treated predominantly by oral medications, with the potential for systemic adverse effects. Successful treatment has been achieved using peribulbar dexamethasone. We assessed the effect of peribulbar dexamethasone or triamcinolone (40-mg Triesence), a longer-acting corticosteroid ...
Rachel Lasry, Marc Gotkine, Joshua M. Kruger   +2 more
openaire   +2 more sources

Ocular Response to Corticotropin in Myasthenia Gravis

Archives of Ophthalmology, 1973
Twenty-two patients who had myasthenia gravis with ptosis, ophthalmoparesis, or both, were treated with massive doses of corticotropin (adrenocorticotrophic hormone). The ocular symptoms in eight of the patients improved significantly. Subsequently, four patients who failed to improve with corticotropin therapy had thymectomies, followed by ...
openaire   +2 more sources

Ocular Myasthenia Gravis

International Ophthalmology Clinics, 2007
Molly E, Gilbert, Peter J, Savino
openaire   +2 more sources

Preliminary Findings of a Dedicated Ocular Myasthenia Gravis Rating Scale: The OMGRate

Neuro-Ophthalmology, 2020
Sui H Wong, Eric Eggenberger, Alba Xhepa   +2 more
exaly  

Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort

Pediatric Neurology, 2021
Kristen S Fisher, Michael B Yang, Michael A Lopez   +2 more
exaly  

Prognosis of Ocular Myasthenia Gravis

Ophthalmology, 2015
João Lemos
exaly  

Do early prednisolone and other immunosuppressant therapies prevent generalization in ocular myasthenia gravis in Western populations: a systematic review and meta-analysis

Therapeutic Advances in Neurological Disorders, 2019
Zhe Ruan, Zhuyi Li, Ting Chang
exaly  

Juvenile Ocular Myasthenia Gravis: Presentation and Outcome of a Large Cohort

Pediatric Neurology, 2018
Tanyatuth Padungkiatsagul, Anuchit Poonyathalang   +1 more
exaly